In one video clip of an annual summary of scientific discoveries for 2014, the narrator calmly stated this astonishing description and conclusion from research conducted this past year (https://www.youtube.com/watch?v=Hjrt0hcv4Qk), using the headline Young Blood Fixes Old:
Scientists stitched [!?!] two [living] mice together, one young, one old, connected their circulatory systems. The connection rejuvenated the brain and the muscle of the older mouse. It appears young blood contains a factor that can turn back the clock on the aging process.
image from http://www.regenexx.com
Exactly how long do you think older, wealthier humans are going to wait before purchasing, enslaving and continuing to exploit younger humans in even more ways, including keeping them STITCHED to their bodies just to utilize their young blood to reverse their own aging???
I am nauseated.
Oh, sure. Scientists could isolate this “factor” and package only that.
But, where will this blood-borne factor be obtained? Exactly how legal, voluntary and frequent (or ongoing!?!) will the processes be for arranging for the young blood donors to fulfill ever-increasing requests for portions (how much?) of their blood?
We already have illegal and questionably-legal markets and practices for:
- organs that can be transplanted, in whole or in part, preserving the donor’s life or not;
- fertilizable human eggs;
- gestational wombs;
- siblings conceived to be organ donors for a needy sibling;
- sexual surrogates (underaged or legal-aged sex slaves of both sexes).
Are you shuddering at the implications of this research, yet? Young people on this planet who have less power and wealth to protect them than those elders who wield power and money like weapons already, should RUN!
image from http://scitechdaily.com
Read Susan Young Rojahn’s May 9, 2014, article, Can Compounds in Young Blood Fix Aging?
Animal studies on the revitalizing power of young blood suggest new drug targets for treating conditions like dementia and heart disease, which summarizes several research studies and their implications, then read the quotes, below.
Based on Wagers’s new and previous results, the Boston-area venture capital firm Atlas Venture has started a still-unnamed company. Wagers’s previous findings caught the eye of the VC firm in 2013, and the new results “increased the excitement for the role of GDF11 in aging,” says partner Peter Barrett. “Now it’s the blocking and tackling of trying to understand what would be the best therapeutic approach to make this a commercial product.”
The wealthier, more powerful of the elders will soon be able to co-opt young blood to keep them from aging. What will stop them?
One of the Stanford researchers, Tony Wyss-Coray, has cofounded a biotech company called Alkahest to test the therapeutic potential of his group’s findings.
image from http://imgur.com
If you’re not terrified, you’re not paying attention.
You must be logged in to post a comment.